Idiopathic Inflammatory Myopathies
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
31564297
DOI
10.1016/j.rdc.2019.07.006
PII: S0889-857X(19)30061-4
Knihovny.cz E-zdroje
- Klíčová slova
- Autoantibodies, Criteria, Exercise, Myositis, Target, Treatment,
- MeSH
- antirevmatika farmakologie MeSH
- autoprotilátky analýza MeSH
- lidé MeSH
- management péče o pacienta metody MeSH
- myozitida * diagnóza imunologie terapie MeSH
- stupeň závažnosti nemoci MeSH
- určení symptomu metody MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- antirevmatika MeSH
- autoprotilátky MeSH
Major advances have been made in the field of idiopathic inflammatory myopathies (IIM), or myositis, that are likely to facilitate development of new therapeutic strategies that have not yet been applied in this group of diseases. These advances include new classification criteria to better identify the patients with IIM, detection of several new myositis-specific autoantibodies that facilitates subgrouping of patients into more specific clinical phenotypes, development of outcome measures for disease activity, and new response criteria. We have learned from clinical studies that exercise is an important part of treatment and that pharmacologic treatment should be combined with exercise.
Citace poskytuje Crossref.org
Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study